On Oct. 25, 2021, Humanigen announced the European Commission had identified lenzilumab as one of the ﾓ10 most promising treatments for COVID-19ﾔ in a report released Oct. 22, 2021. Lenzilumab was chosen as one of the 10 most promising COVID-19 treatments after an evaluation of 82 late-stage therapeutic candidates by an independent group of 10 scientific experts across Europe.